Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT
Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT
Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT, USA; Humanitas Clinical and Research Center, IRCCS, Rozzano
School of Public Health, Yale Center for Analytical Sciences, Yale University, New Haven, CT
Department of Data Science, Dana Farber Cancer Institute, Boston, MA
Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT
Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
Washington University School of Medicine, Saint Louis, MO
Washington University School of Medicine, Saint Louis, MO
Department of Hematology and Medical Oncology, Taussig Cancer Institute, Leukemia Program, Cleveland Clinic, Cleveland, OH
Weill Cornell Medicine, New York City, NY
Roswell Park Comprehensive Cancer Center, Buffalo, NY
Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York City, NY
Division of Hematology/Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
University of Colorado, Aurora, CO
Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL
University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT
Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT
Weill Cornell Medicine, New York City, NY
Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
Roswell Park Comprehensive Cancer Center, Buffalo, NY
Division of Hematology/Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
University of Colorado, Aurora, CO
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN
Weill Cornell Medicine, New York City, NY
Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL
Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
Northwestern University, Chicago
Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL
Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL
MLL Munich Leukemia Laboratory, Munich
Department of Hematology and Medical Oncology, Taussig Cancer Institute, Leukemia Program, Cleveland Clinic, Cleveland, OH
Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
Hématologie Seniors, Assistance Publique - Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
Department of Haematology, Calvary Mater Hospital, Newcastle, New South Wales
King Hussein Cancer Center, Amman
King Hussein Cancer Center, Amman
Department of Haematology, The Royal Adelaide Hospital, Adelaide
Hematology Department, Institute of Biomedical Research of Salamanca, University Hospital of Salamanca, Salamanca
Department of Hematology and Oncology, University Hospital Vall d'Hebron, Barcelona
MLL Munich Leukemia Laboratory, Munich
3rd Medical Department with Hematology, Medical Oncology, Hemostaseology, Rheumatology and Infectiology, Oncologic Center, Paracelsus Medical University, Salzburg
Department of Hematology, Democritus University of Thrace Medical School, Alexandroupolis
Hematology Division, Second Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, Athens
MDS Unit, Hematology, AOU Careggi ‐ Department of Experimental and Clinical Medicine, University of Florence, Florence
MDS Unit, Hematology, AOU Careggi ‐ Department of Experimental and Clinical Medicine, University of Florence, Florence
Mayo Clinic, Rochester, MN
DDepartment of Pathology and Tumor Biology, Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan; Department of Innovative Medicine, Faculty of Medicine, Kindai University, Osaka
Institute of Medical Science, the University of Tokyo, Tokyo
Humanitas Clinical and Research Center, IRCCS, Rozzano
Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL
Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT
